Introducing Professor Peter Dettmar

Introducing Professor Peter Dettmar

Professor Peter Dettmar has been working on reflux since 1981 and is a world-leading expert on using the stomach enzyme pepsin as a marker for the disease. In his former role as global R&D Director of Gastrointestinals for Reckitt Benckiser Healthcare, Professor...
What is anti-reflux mucosectomy (ARMS)?

What is anti-reflux mucosectomy (ARMS)?

Proton pump inhibitors (PPIs) are used to manage gastro-oesophageal reflux disease symptoms, but many people do not respond well to the medication. The next option is anti-reflux surgery with a variety of endoscopic therapies now available, including STRETTA, MUSE and...
Peptest used to evaluate reflux surgery success

Peptest used to evaluate reflux surgery success

Peptest has been used to evaluate the success of laparoscopic fundoplication surgery for the treatment of reflux disease in a new research study. Laparoscopic fundoplication surgery is when the top part of the stomach is wrapped around the lower part of the oesophagus...
Peptest showcased at China conference on reflux

Peptest showcased at China conference on reflux

Maxhealth Medical Group, Peptest’s Chinese distributor, has presented the non-invasive device for diagnosing reflux to key opinion leaders at a China conference in November. The China Healthcare International Association, Gastroesophageal Reflux and Multidisciplinary...
Risk of reflux rises with age

Risk of reflux rises with age

As age increases so does the tendency to suffer from laryngopharyngeal reflux (LPR) – according to a new research study. Researchers in Italy have found a significant correlation between increase in age and an increase in pepsin within the oesophagus. Pepsin is a...